New data shows Alzheimer's drug can benefit some patients
04:58
Share this -
copied
Dr. Madhav Thambisetty of Johns Hopkins School of Medicine joins Morning Joe to discus the results of a clinical trial of an experimental Alzheimer’s drug that suggest that the treatment slowed cognitive decline somewhat for people in the early stages of the disease.Nov. 30, 2022
UP NEXT
Joe: Democracy is on the line when Trump says Jan. 6 rioting is normal political behavior
10:53
Biden anxious and angry behind the scenes about re-election effort
06:40
'American Sycamore' author says novel is about good people facing difficult times
03:01
Putin feels he has nothing to lose inside Russia, warns Economist editor
06:22
Michael Beschloss: We have never seen anything remotely like this in U.S. history
05:17
'The people in Ukraine are my heroes,' says actress and activist Ivanna Sakhno